UB Paderborn / Katalog / Suche / in CDI

Risk factors for appendiceal involvement in women with epithelial ovarian cancer

Journal of the Turkish German Gynecological Association, 2017-09, Vol.18 (3), p.116-121

2017

Volltextzugriff (PDF)

Effect of Adjuvant Therapy on Oncologic Outcomes of Surgically Confirmed Stage I Uterine Carcinosarcoma: a Turkish Gynecologic Oncology Study

Balkan medical journal, 2019-07, Vol.36 (4), p.229-234

2019

Volltextzugriff (PDF)

Prognostic factors and survival outcomes of women with uterine leiomyosarcoma: A Turkish Uterine Sarcoma Group Study-003

Current problems in cancer, 2021-10, Vol.45 (5), p.100712-100712, Article 100712

2021

Volltextzugriff (PDF)

What is the impact of stromal microinvasion on oncologic outcomes in borderline ovarian tumors? A multicenter case–control study

Archives of gynecology and obstetrics, 2017-11, Vol.296 (5), p.979-987

2017

Volltextzugriff (PDF)

Impact of lymph node ratio on survival in stage III ovarian high-grade serous cancer: a Turkish Gynecologic Oncology Group study

Journal of Gynecologic Oncology, 2018, 29(1), , pp.1-10

2018

Volltextzugriff (PDF)

HPV Vaccines: Current Status

Gynecology, obstetrics & reproductive medicine : GORM, 2017-04, Vol.23 (1), p.54-59

2017

Volltextzugriff (PDF)

Carcinosarcoma of the ovary compared to ovarian high-grade serous carcinoma: impact of optimal cytoreduction and standard adjuvant treatment

International journal of clinical oncology, 2018-04, Vol.23 (2), p.329-337

2018

Volltextzugriff (PDF)

Is the extent of lymphadenectomy a prognostic factor in International Federation of Gynecology and Obstetrics stage II endometrioid endometrial cancer?

The journal of obstetrics and gynaecology research, 2021-03, Vol.47 (3), p.1134-1144

2021

Volltextzugriff (PDF)

Uterine adenosarcomas: A dual-institution experience

Journal of obstetrics and gynaecology, 2017-01, Vol.37 (1), p.93-96

2017

Volltextzugriff (PDF)

Iatrogenic implantation of placental tissue after first trimester dilatation and curettage presenting as a uterine mass: A report of two cases

Journal of obstetrics and gynaecology, 2017-08, Vol.37 (6), p.801-803

2017

Volltextzugriff (PDF)

What is the prognostic importance of lymphovascular space invasion in the absence of lymph node metastasis for early-stage endometrial cancer?

Journal of Gynecologic Oncology, 2021, 32(5), , pp.1-2

2021

Volltextzugriff (PDF)

Adenoid Basal Carcinoma of Uterine Cervix: A Case Report

Gynecology, obstetrics & reproductive medicine : GORM, 2016-12, Vol.22 (3), p.174-176

2016

Volltextzugriff (PDF)

Prognostic significance of lymphovascular space invasion in low-risk endometrial cancer

International journal of gynecological cancer, 2019-03, Vol.29 (3), p.505-512

2019

Volltextzugriff (PDF)

The prognostic value of lymph node ratio in stage IIIC cervical cancer patients triaged to primary treatment by radical hysterectomy with systematic pelvic and para-aortic lymphadenectomy

Journal of Gynecologic Oncology, 2020, 31(1), , pp.1-13

2020

Volltextzugriff (PDF)

Is the revised 2018 FIGO staging system for cervical cancer more prognostic than the 2009 FIGO staging system for women previously staged as IB disease?

European journal of obstetrics & gynecology and reproductive biology, 2019-09, Vol.240, p.209-214

2019

Volltextzugriff (PDF)

Impact of adjuvant treatments and risk factors on survival in 2023 FIGO stage IIB endometrial cancer patients: Turkish Gynecologic Oncology Group Study

International journal of gynecological cancer, 2024-06, Vol.34 (9), p.1382-1388

2024

Volltextzugriff (PDF)

Risk factors for paraaortic lymph node metastasis in endometrial cancer

International journal of clinical oncology, 2017-10, Vol.22 (5), p.937-944

2017

Volltextzugriff (PDF)

Prognostic value of the number of the metastatic lymph nodes in locally early-stage cervical cancer: squamous cell carcinoma versus non-squamous cell carcinoma

Archives of gynecology and obstetrics, 2021-11, Vol.304 (5), p.1279-1289

2021

Volltextzugriff (PDF)

Impact of cytoreductive surgery on survival of patients with low‐grade serous ovarian carcinoma: A multicentric study of Turkish Society of Gynecologic Oncology (TRSGO‐OvCa‐001)

Journal of surgical oncology, 2021-05, Vol.123 (8), p.1801-1810

2021

Volltextzugriff (PDF)

Is Tumor Size Really Important for Prediction of Lymphatic Dissemination in Grade 1 Endometrial Carcinoma With Superficial Myometrial Invasion?

International journal of gynecological cancer, 2017-09, Vol.27 (7), p.1393-1398

2017

Volltextzugriff (PDF)

2022-RA-1174-ESGO Role of adjuvant therapy in intermediate-risk cervical cancer patients – SCCAN study sub-analysis

International journal of gynecological cancer, 2022-10, Vol.32 (Suppl 2), p.A44-A44

2022

Volltextzugriff (PDF)

High-grade endometrial stromal sarcoma versus undifferentiated uterine sarcoma: a Turkish uterine sarcoma group study-001

Archives of gynecology and obstetrics, 2021-08, Vol.304 (2), p.475-483

2021

Volltextzugriff (PDF)

Risk of Malignancy Index Has a Poor Sensitivity in Detecting Borderline Epithelial Tumors and Non-Epithelial Ovarian Tumors

Gynecology, obstetrics & reproductive medicine : GORM, 2019-08, Vol.25 (2), p.101-106

2019

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Risk factors for appendiceal involvement in women with epithelial ovarian cancer

Effect of Adjuvant Therapy on Oncologic Outcomes of Surgically Confirmed Stage I Uterine Carcinosarcoma: a Turkish Gynecologic Oncology Study

Prognostic factors and survival outcomes of women with uterine leiomyosarcoma: A Turkish Uterine Sarcoma Group Study-003

What is the impact of stromal microinvasion on oncologic outcomes in borderline ovarian tumors? A multicenter case–control study

Impact of lymph node ratio on survival in stage III ovarian high-grade serous cancer: a Turkish Gynecologic Oncology Group study

HPV Vaccines: Current Status

Carcinosarcoma of the ovary compared to ovarian high-grade serous carcinoma: impact of optimal cytoreduction and standard adjuvant treatment

Is the extent of lymphadenectomy a prognostic factor in International Federation of Gynecology and Obstetrics stage II endometrioid endometrial cancer?

Uterine adenosarcomas: A dual-institution experience

Factors associated with survival after relapse in patients with low-risk endometrial cancer treated with surgery alone

Iatrogenic implantation of placental tissue after first trimester dilatation and curettage presenting as a uterine mass: A report of two cases

Prognostic factors and treatment outcomes in surgically-staged non-invasive uterine clear cell carcinoma: a Turkish Gynecologic Oncology Group study

What is the prognostic importance of lymphovascular space invasion in the absence of lymph node metastasis for early-stage endometrial cancer?

Adenoid Basal Carcinoma of Uterine Cervix: A Case Report

Prognostic significance of lymphovascular space invasion in low-risk endometrial cancer

The prognostic value of lymph node ratio in stage IIIC cervical cancer patients triaged to primary treatment by radical hysterectomy with systematic pelvic and para-aortic lymphadenectomy

Is the revised 2018 FIGO staging system for cervical cancer more prognostic than the 2009 FIGO staging system for women previously staged as IB disease?

Impact of adjuvant treatments and risk factors on survival in 2023 FIGO stage IIB endometrial cancer patients: Turkish Gynecologic Oncology Group Study

Risk factors for paraaortic lymph node metastasis in endometrial cancer

Prognostic value of the number of the metastatic lymph nodes in locally early-stage cervical cancer: squamous cell carcinoma versus non-squamous cell carcinoma

Impact of cytoreductive surgery on survival of patients with low‐grade serous ovarian carcinoma: A multicentric study of Turkish Society of Gynecologic Oncology (TRSGO‐OvCa‐001)

Is Tumor Size Really Important for Prediction of Lymphatic Dissemination in Grade 1 Endometrial Carcinoma With Superficial Myometrial Invasion?

2022-RA-1174-ESGO Role of adjuvant therapy in intermediate-risk cervical cancer patients – SCCAN study sub-analysis

High-grade endometrial stromal sarcoma versus undifferentiated uterine sarcoma: a Turkish uterine sarcoma group study-001

Risk of Malignancy Index Has a Poor Sensitivity in Detecting Borderline Epithelial Tumors and Non-Epithelial Ovarian Tumors

Suchergebnisse filtern